B. Metzler seel. Sohn & Co. AG Invests $7.08 Million in The Ensign Group, Inc. $ENSG

Key Points

• B. Metzler seel. Sohn & Co. AG purchased 44,181 shares of The Ensign Group in the second quarter, valued at approximately $7.08 million, giving it a roughly 0.08% stake. Institutional investors collectively own 96.12% of the company.
• Analyst sentiment remains positive but tempered, with four Buy ratings and two Holds, producing a “Moderate Buy” consensus and an average price target of $216.25. Recent actions included downgrades from Wall Street Zen and Weiss Ratings, while RBC maintained an Outperform rating.
• The company exceeded quarterly earnings expectations, reporting $1.92 in EPS versus a $1.80 consensus estimate, while revenue rose 16.7% year over year to $1.44 billion. Ensign also declared a quarterly dividend of $0.065 per share, equivalent to a 0.1% annualized yield.

B. Metzler seel. Sohn & Co. AG purchased a new stake in The Ensign Group, Inc. (NASDAQ:ENSG - Free Report) in the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The fund purchased 44,181 shares of the company's stock, valued at approximately $7,082,000. B. Metzler seel. Sohn & Co. AG owned approximately 0.08% of The Ensign Group as of its most recent SEC filing.

A number of other large investors have also modified their holdings of the business. Private Trust Co. NA increased its holdings in shares of The Ensign Group by 156.5% during the 4th quarter. Private Trust Co. NA now owns 159 shares of the company's stock worth $28,000 after buying an additional 97 shares during the last quarter. Monetary Solutions Ltd acquired a new position in shares of The Ensign Group in the fourth quarter valued at approximately $30,000. Northwestern Mutual Wealth Management Co. lifted its stake in shares of The Ensign Group by 55.0% in the 4th quarter. Northwestern Mutual Wealth Management Co. now owns 172 shares of the company's stock worth $30,000 after acquiring an additional 61 shares during the period. Bayban purchased a new stake in The Ensign Group in the 4th quarter valued at approximately $31,000. Finally, Cedar Mountain Advisors LLC purchased a new position in The Ensign Group in the first quarter worth $32,000. Hedge funds and other institutional investors own 96.12% of the company's stock.

Wall Street Analyst Weigh In

Several brokerages recently issued reports on ENSG. Wall Street Zen downgraded The Ensign Group from a "buy" rating to a "hold" rating in a research report on Saturday, July 25th. Weiss Ratings lowered The Ensign Group from a "buy (b)" rating to a "buy (b-)" rating in a research report on Tuesday, June 16th. Royal Bank Of Canada reissued an "outperform" rating and issued a $228.00 target price on shares of The Ensign Group in a report on Tuesday, July 28th. Finally, Truist Financial increased their price target on The Ensign Group from $202.00 to $207.00 and gave the company a "hold" rating in a research report on Thursday, July 30th. Four research analysts have rated the stock with a Buy rating and two have given a Hold rating to the stock. According to data from MarketBeat, the stock presently has an average rating of "Moderate Buy" and an average price target of $216.25.

Insider Activity

In other news, Director John O. Agwunobi sold 392 shares of the company's stock in a transaction that occurred on Monday, July 20th. The stock was sold at an average price of $171.06, for a total transaction of $67,055.52. Following the completion of the transaction, the director directly owned 9,503 shares of the company's stock, valued at $1,625,583.18. This represents a 3.96% decrease in their position. The sale was disclosed in a filing with the SEC, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Barry M. Smith sold 700 shares of the stock in a transaction that occurred on Tuesday, June 2nd. The shares were sold at an average price of $164.28, for a total value of $114,996.00. Following the transaction, the director owned 21,352 shares in the company, valued at $3,507,706.56. This trade represents a 3.17% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Corporate insiders own 4.00% of the company's stock.

The Ensign Group Stock Performance

Shares of ENSG opened at $179.48 on Friday. The Ensign Group, Inc. has a twelve month low of $141.58 and a twelve month high of $218.00. The firm's 50 day moving average price is $171.11 and its two-hundred day moving average price is $184.42. The firm has a market cap of $10.46 billion, a P/E ratio of 28.13, a PEG ratio of 1.73 and a beta of 0.68. The company has a debt-to-equity ratio of 0.06, a quick ratio of 1.21 and a current ratio of 1.21.

The Ensign Group (NASDAQ:ENSG - Get Free Report) last released its quarterly earnings data on Monday, July 27th. The company reported $1.92 EPS for the quarter, beating the consensus estimate of $1.80 by $0.12. The company had revenue of $1.44 billion during the quarter, compared to the consensus estimate of $1.44 billion. The Ensign Group had a return on equity of 16.75% and a net margin of 6.90%.The firm's revenue for the quarter was up 16.7% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $1.59 EPS. The Ensign Group has set its FY 2026 guidance at 7.750-7.850 EPS. On average, analysts forecast that The Ensign Group, Inc. will post 6.93 EPS for the current fiscal year.

The Ensign Group Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Friday, July 31st. Investors of record on Tuesday, June 30th were given a $0.065 dividend. This represents a $0.26 dividend on an annualized basis and a yield of 0.1%. The ex-dividend date of this dividend was Tuesday, June 30th. The Ensign Group's payout ratio is presently 4.08%.

The Ensign Group Company Profile

The Ensign Group, Inc is a diversified provider of post-acute healthcare services in the United States, operating a network of skilled nursing, assisted living, independent living, home health and hospice care centers. The company's model emphasizes integrated care by employing multidisciplinary teams—including nursing staff, therapists and physicians—to deliver personalized rehabilitation and long-term care services for seniors and other patients recovering from injury, illness or surgery.

Through its owned and managed centers, The Ensign Group offers a broad spectrum of rehabilitation services such as physical, occupational and speech therapy.

Want to see what other hedge funds are holding ENSG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Ensign Group, Inc. (NASDAQ:ENSG - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source